- Article
Plocabulin Displays Strong Cytotoxic Activity in a Personalized Colon Cancer Patient-Derived 3D Organoid Assay
- Alba Costales-Carrera,
- Asunción Fernández-Barral,
- Pilar Bustamante-Madrid,
- Laura Guerra,
- Ramón Cantero,
- Antonio Barbáchano and
- Alberto Muñoz
Plocabulin is a novel microtubule-disrupting antitumor agent of marine origin that is currently undergoing phase II clinical trials. Plocabulin has potent antiproliferative and antiangiogenic actions in carcinoma cell lines and has antitumor activity...

